Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Phenotyping acute and chronic atopic dermatitis-like lesions in Stat6VT mice identifies a role for IL-33 in disease pathogenesis.

DaSilva-Arnold SC, Thyagarajan A, Seymour LJ, Yi Q, Bradish JR, Al-Hassani M, Zhou H, Perdue NJ, Nemeth V, Krbanjevic A, Serezani APM, Olson MR, Spandau DF, Travers JB, Kaplan MH, Turner MJ.

Arch Dermatol Res. 2018 Apr;310(3):197-207. doi: 10.1007/s00403-018-1807-y. Epub 2018 Jan 24.

PMID:
29368135
2.

IL-4 impairs wound healing potential in the skin by repressing fibronectin expression.

Serezani APM, Bozdogan G, Sehra S, Walsh D, Krishnamurthy P, Sierra Potchanant EA, Nalepa G, Goenka S, Turner MJ, Spandau DF, Kaplan MH.

J Allergy Clin Immunol. 2017 Jan;139(1):142-151.e5. doi: 10.1016/j.jaci.2016.07.012. Epub 2016 Aug 20.

3.

Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.

Sehra S, Serezani APM, Ocaña JA, Travers JB, Kaplan MH.

J Invest Dermatol. 2016 Jul;136(7):1429-1437. doi: 10.1016/j.jid.2016.03.019. Epub 2016 Mar 25.

4.

What potential do heterobivalent inhibitors have for the treatment of severe allergic reactions?

Handlogten MW, Serezani AP, Kaplan MH, Bilgicer B.

Immunotherapy. 2014;6(3):223-5. doi: 10.2217/imt.14.1. No abstract available.

5.

A heterobivalent ligand inhibits mast cell degranulation via selective inhibition of allergen-IgE interactions in vivo.

Handlogten MW, Serezani AP, Sinn AL, Pollok KE, Kaplan MH, Bilgicer B.

J Immunol. 2014 Mar 1;192(5):2035-41. doi: 10.4049/jimmunol.1301371. Epub 2014 Jan 31.

6.

PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis.

Ferreira AE, Sisti F, Sônego F, Wang S, Filgueiras LR, Brandt S, Serezani AP, Du H, Cunha FQ, Alves-Filho JC, Serezani CH.

J Immunol. 2014 Mar 1;192(5):2357-65. doi: 10.4049/jimmunol.1302375. Epub 2014 Jan 31.

7.

Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation.

Wang Z, Filgueiras LR, Wang S, Serezani AP, Peters-Golden M, Jancar S, Serezani CH.

J Immunol. 2014 Mar 1;192(5):2349-56. doi: 10.4049/jimmunol.1302982. Epub 2014 Jan 29.

8.

Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation.

Handlogten MW, Kiziltepe T, Serezani AP, Kaplan MH, Bilgicer B.

Nat Chem Biol. 2013 Dec;9(12):789-95. doi: 10.1038/nchembio.1358. Epub 2013 Oct 6.

Supplemental Content

Loading ...
Support Center